Uselessness of Serum P53 Antibody for Detecting Colitis-Associated Cancer in the Era of Immunosuppressive Therapy

In Vivo - Greece
doi 10.21873/invivo.11830
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.

Related search

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Post-Colonoscopic Listeria Septicemia in Ulcerative Colitis During Immunosuppressive Therapy

Internal Medicine
Internal MedicineMedicine
2007English

The Tumor Immunosuppressive Microenvironment Impairs the Therapy of Anti-Her2/Neu Antibody

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2012English

Murine Model for Colitis-Associated Cancer of the Colon

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Use of P53 for Therapy of Human Cancer

Molecular Biology
Structural BiologyBiophysics
2007English

Cyclosporine-Associated Neurotoxicity: The Need for a Better Guide for Immunosuppressive Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1996English

AOM/DSS Model of Colitis-Associated Cancer

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Targeting P53-Mdm2-MDMX Loop for Cancer Therapy

Sub-Cellular Biochemistry
BiochemistryCancer ResearchCell BiologyMolecular Biology
2014English

Targeted Deletion of P53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer

Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy